These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36562107)

  • 1. Opioid-induced microbial dysbiosis disrupts irinotecan (CPT-11) metabolism and increases gastrointestinal toxicity in a murine model.
    Meng J; Abu YF; Zhang Y; Zhou Y; Xie Y; Yan Y; Tao J; Ramakrishnan S; Chen C; Roy S
    Br J Pharmacol; 2023 May; 180(10):1362-1378. PubMed ID: 36562107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of intestinal microflora beta-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats.
    Takasuna K; Hagiwara T; Hirohashi M; Kato M; Nomura M; Nagai E; Yokoi T; Kamataki T
    Cancer Chemother Pharmacol; 1998; 42(4):280-6. PubMed ID: 9744772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological inhibition of bacterial β-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo.
    Cheng KW; Tseng CH; Tzeng CC; Leu YL; Cheng TC; Wang JY; Chang JM; Lu YC; Cheng CM; Chen IJ; Cheng YA; Chen YL; Cheng TL
    Pharmacol Res; 2019 Jan; 139():41-49. PubMed ID: 30391354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organic Anion Transporting Polypeptide (OATP)2B1 Contributes to Gastrointestinal Toxicity of Anticancer Drug SN-38, Active Metabolite of Irinotecan Hydrochloride.
    Fujita D; Saito Y; Nakanishi T; Tamai I
    Drug Metab Dispos; 2016 Jan; 44(1):1-7. PubMed ID: 26526067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy.
    Bhatt AP; Pellock SJ; Biernat KA; Walton WG; Wallace BD; Creekmore BC; Letertre MM; Swann JR; Wilson ID; Roques JR; Darr DB; Bailey ST; Montgomery SA; Roach JM; Azcarate-Peril MA; Sartor RB; Gharaibeh RZ; Bultman SJ; Redinbo MR
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7374-7381. PubMed ID: 32170007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats.
    Takasuna K; Hagiwara T; Hirohashi M; Kato M; Nomura M; Nagai E; Yokoi T; Kamataki T
    Cancer Res; 1996 Aug; 56(16):3752-7. PubMed ID: 8706020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local enzymatic hydrolysis of an endogenously generated metabolite can enhance CPT-11 anticancer efficacy.
    Prijovich ZM; Chen KC; Roffler SR
    Mol Cancer Ther; 2009 Apr; 8(4):940-6. PubMed ID: 19372567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of β-glucuronidase activity in intestinal lumen.
    Kurita A; Kado S; Matsumoto T; Asakawa N; Kaneda N; Kato I; Uchida K; Onoue M; Yokokura T
    Cancer Chemother Pharmacol; 2011 Jan; 67(1):201-13. PubMed ID: 20354702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide.
    Yang XX; Hu ZP; Chan SY; Duan W; Ho PC; Boelsterli UA; Ng KY; Chan E; Bian JS; Chen YZ; Huang M; Zhou SF
    Curr Drug Metab; 2006 May; 7(4):431-55. PubMed ID: 16724931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into the mechanism of Xiao-Chai-Hu-Tang alleviates irinotecan-induced diarrhea based on regulating the gut microbiota and inhibiting Gut β-GUS.
    Wang C; Teng X; Wang C; Liu B; Zhou R; Xu X; Qiu H; Fu Y; Sun R; Liang Z; Zhang R; Liu Z; Zhang L; Zhu L
    Phytomedicine; 2023 Nov; 120():155040. PubMed ID: 37683587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Tissue Omega-6/Omega-3 Fatty Acid Ratio Prevents Chemotherapy-Induced Gastrointestinal Toxicity Associated with Alterations of Gut Microbiome.
    Kaliannan K; Donnell SO; Murphy K; Stanton C; Kang C; Wang B; Li XY; Bhan AK; Kang JX
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular insights into microbial β-glucuronidase inhibition to abrogate CPT-11 toxicity.
    Roberts AB; Wallace BD; Venkatesh MK; Mani S; Redinbo MR
    Mol Pharmacol; 2013 Aug; 84(2):208-17. PubMed ID: 23690068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity.
    Mahdy MS; Azmy AF; Dishisha T; Mohamed WR; Ahmed KA; Hassan A; Aidy SE; El-Gendy AO
    BMC Microbiol; 2023 Mar; 23(1):53. PubMed ID: 36864380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea.
    Takasuna K; Hagiwara T; Watanabe K; Onose S; Yoshida S; Kumazawa E; Nagai E; Kamataki T
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):494-503. PubMed ID: 16437251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of tumor glucuronidase in the activation of irinotecan in a mouse xenograft model.
    Dodds HM; Tobin PJ; Stewart CF; Cheshire P; Hanna S; Houghton P; Rivory LP
    J Pharmacol Exp Ther; 2002 Nov; 303(2):649-55. PubMed ID: 12388647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total Flavonoids of
    Yue SJ; Qin YF; Kang A; Tao HJ; Zhou GS; Chen YY; Jiang JQ; Tang YP; Duan JA
    Front Immunol; 2021; 12():628358. PubMed ID: 34025639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Old drug new use--amoxapine and its metabolites as potent bacterial β-glucuronidase inhibitors for alleviating cancer drug toxicity.
    Kong R; Liu T; Zhu X; Ahmad S; Williams AL; Phan AT; Zhao H; Scott JE; Yeh LA; Wong ST
    Clin Cancer Res; 2014 Jul; 20(13):3521-30. PubMed ID: 24780296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of irinotecan and its active metabolite SN-38 by intestinal microflora in rats.
    Yamamoto M; Kurita A; Asahara T; Takakura A; Katono K; Iwasaki M; Ryuge S; Wada M; Onoda S; Yanaihara T; Yokoba M; Mitsufuji H; Nishii Y; Fukui T; Masuda N
    Oncol Rep; 2008 Oct; 20(4):727-30. PubMed ID: 18813810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme.
    Wallace BD; Wang H; Lane KT; Scott JE; Orans J; Koo JS; Venkatesh M; Jobin C; Yeh LA; Mani S; Redinbo MR
    Science; 2010 Nov; 330(6005):831-5. PubMed ID: 21051639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rh4 alleviates gastrointestinal mucositis and enhances chemotherapy efficacy through modulating gut microbiota.
    Bai X; Deng J; Duan Z; Fu R; Zhu C; Fan D
    Phytomedicine; 2024 Jun; 128():155577. PubMed ID: 38608488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.